Emtricitabine/Tenofovir Disoproxil Macleods

Emtricitabine/Tenofovir Disoproxil Macleods is a combination medication used for HIV treatment and prevention. This oral medication is manufactured by Macleods Pharma España, S.L.U.

Emtricitabine/Tenofovir Disoproxil Macleods is primarily used in the management of HIV infection. It is often prescribed as part of a combination therapy to help control the virus and reduce the risk of transmission. This medication is also used for pre-exposure prophylaxis (PrEP) in individuals at high risk of HIV infection. The active ingredients, emtricitabine and tenofovir disoproxil fumarate, work together to inhibit the replication of the HIV virus.

Common effects of Emtricitabine/Tenofovir Disoproxil Macleods may include headaches, nausea, and fatigue. Some individuals may experience dizziness or diarrhea. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Emtricitabine/Tenofovir Disoproxil Macleods should be used with caution in individuals with kidney problems. Regular monitoring of kidney function is recommended. It is important to follow the prescribed dosage and not to share this medication with others. Always store the medication in a cool, dry place away from direct sunlight.

Emtricitabine/Tenofovir Disoproxil Macleods may interact with other medications, including certain antibiotics, antifungals, and HIV medications. Alcohol consumption should be limited as it may exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.